Hospital Universitari de Bellvitge -ko ikertzaileekin lankidetzan egindako argitalpenak (16)

2024

  1. Generation and External Validation of a Histologic Transformation Risk Model for Patients with Follicular Lymphoma

    Modern Pathology, Vol. 37, Núm. 7

  2. Renal Disease in Metabolic Syndrome: the Hidden Role of Intrarenal Ischemia

    Kidney International Reports, Vol. 9, Núm. 5, pp. 1419-1428

2022

  1. Treatment of early borderline lesions in low immunological risk kidney transplant patients: a Spanish multicenter, randomized, controlled parallel-group study protocol: the TRAINING study

    BMC Nephrology, Vol. 23, Núm. 1

2021

  1. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  2. The Role of Vascular Lesions in Diabetes Across a Spectrum of Clinical Kidney Disease

    Kidney International Reports, Vol. 6, Núm. 9, pp. 2392-2403

  3. Validation of a Histologic Scoring Index for C3 Glomerulopathy

    American Journal of Kidney Diseases, Vol. 77, Núm. 5, pp. 684-695.e1

2019

  1. Differential aggregation and phosphorylation of alpha synuclein in membrane compartments associated with Parkinson disease

    Frontiers in Neuroscience, Vol. 13, Núm. APR

  2. Impact of exposure of emergency patients with acute heart failure to atmospheric Saharan desert dust

    Emergencias : revista de la Sociedad Espanola de Medicina de Emergencias, Vol. 31, Núm. 3, pp. 161-166

2017

  1. Anomalies occurring in lipid profiles and protein distribution in frontal cortex lipid rafts in dementia with Lewy bodies disclose neurochemical traits partially shared by Alzheimer's and Parkinson's diseases

    Neurobiology of Aging, Vol. 49, pp. 52-59

  2. Lipid raft ER signalosome malfunctions in menopause and Alzheimer's disease

    Frontiers in Bioscience - Scholar, Vol. 9, Núm. 1, pp. 111-126

2015

  1. Nuclear DICKKOPF-1 as a biomarker of chemoresistance and poor clinical outcome in colorectal cancer

    Oncotarget, Vol. 6, Núm. 8, pp. 5903-5917

2014

  1. Altered lipid composition in cortical lipid rafts occurs at early stages of sporadic Alzheimer's disease and facilitates APP/BACE1 interactions

    Neurobiology of Aging, Vol. 35, Núm. 8, pp. 1801-1812

  2. Aβ promotes VDAC1 channel dephosphorylation in neuronal lipid rafts. Relevance to the mechanisms of neurotoxicity in Alzheimer's disease

    Neuroscience, Vol. 278, pp. 354-366

  3. Biophysical alterations in lipid rafts from human cerebral cortex associate with increased BACE1/AβPP interaction in early stages of Alzheimer's disease

    Journal of Alzheimer's Disease, Vol. 43, Núm. 4, pp. 1185-1198

2010

  1. Lipid alterations in lipid rafts from Alzheimer's disease human brain cortex

    Journal of Alzheimer's Disease, Vol. 19, Núm. 2, pp. 489-502

2009

  1. VDAC and ERα interaction in caveolae from human cortex is altered in Alzheimer's disease

    Molecular and Cellular Neuroscience, Vol. 42, Núm. 3, pp. 172-183